image
Healthcare - Medical - Healthcare Plans - NYSE - US
$ 315.39
-2.17 %
$ 85.5 B
Market Cap
26.02
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one CI stock under the worst case scenario is HIDDEN Compared to the current market price of 315 USD, Cigna Corporation is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one CI stock under the base case scenario is HIDDEN Compared to the current market price of 315 USD, Cigna Corporation is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one CI stock under the best case scenario is HIDDEN Compared to the current market price of 315 USD, Cigna Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart CI

image
$360.0$360.0$350.0$350.0$340.0$340.0$330.0$330.0$320.0$320.0$310.0$310.0$300.0$300.0$290.0$290.0$280.0$280.0$270.0$270.0$260.0$260.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
247 B REVENUE
26.61%
9.42 B OPERATING INCOME
10.32%
3.78 B NET INCOME
-26.84%
10.4 B OPERATING CASH FLOW
-12.27%
-2.1 B INVESTING CASH FLOW
59.37%
-7.65 B FINANCING CASH FLOW
-78.09%
65.7 B REVENUE
3.18%
0 OPERATING INCOME
0.00%
1.54 B NET INCOME
86.18%
5.21 B OPERATING CASH FLOW
11230.43%
-191 M INVESTING CASH FLOW
75.39%
-3.25 B FINANCING CASH FLOW
-739.86%
Balance Sheet Cigna Corporation
image
Current Assets 48.9 B
Cash & Short-Term Investments 7.55 B
Receivables 24.2 B
Other Current Assets 17.1 B
Non-Current Assets 107 B
Long-Term Investments 15.1 B
PP&E 3.96 B
Other Non-Current Assets 87.9 B
4.84 %15.54 %10.97 %9.70 %56.41 %Total Assets$155.9b
Current Liabilities 58 B
Accounts Payable 9.29 B
Short-Term Debt 3.04 B
Other Current Liabilities 45.6 B
Non-Current Liabilities 56.7 B
Long-Term Debt 28.9 B
Other Non-Current Liabilities 27.7 B
8.11 %39.82 %25.24 %24.18 %Total Liabilities$114.6b
EFFICIENCY
Earnings Waterfall Cigna Corporation
image
Revenue 247 B
Cost Of Revenue 0
Gross Profit 247 B
Operating Expenses 244 B
Operating Income 9.42 B
Other Expenses 5.64 B
Net Income 3.78 B
250b250b200b200b150b150b100b100b50b50b00247b0247b(244b)9b(6b)4bRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
100.00% GROSS MARGIN
100.00%
3.81% OPERATING MARGIN
3.81%
0.14% NET MARGIN
0.14%
0.84% ROE
0.84%
0.22% ROA
0.22%
0.61% ROIC
0.61%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Cigna Corporation
image
12b12b10b10b8b8b6b6b4b4b2b2b0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 3.78 B
Depreciation & Amortization 2.78 B
Capital Expenditures -1.41 B
Stock-Based Compensation 0
Change in Working Capital 1.19 B
Others 11.2 B
Free Cash Flow 8.96 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Cigna Corporation
image
Wall Street analysts predict an average 1-year price target for CI of $378 , with forecasts ranging from a low of $341 to a high of $407 .
CI Lowest Price Target Wall Street Target
341 USD 8.12%
CI Average Price Target Wall Street Target
378 USD 19.97%
CI Highest Price Target Wall Street Target
407 USD 29.05%
Price
Max Price Target
Min Price Target
Average Price Target
420420400400380380360360340340320320300300280280260260May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
0.49% DIVIDEND YIELD
1.51 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
4.504.504.004.003.503.503.003.002.502.502.002.001.501.501.001.000.500.500.000.0011.121.231.41.5111.121.231.411.121.231.413.041.123.401.233.731.44.240.040.041.001.121.231.401.512015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 7
6. Ownership
Insider Ownership Cigna Corporation
image
Sold
0-3 MONTHS
13.6 M USD 4
3-6 MONTHS
0 USD 0
6-9 MONTHS
10.5 M USD 3
9-12 MONTHS
7.98 M USD 4
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
The Cigna Group's First Quarter 2025 Earnings Release Details BLOOMFIELD, Conn. , April 4, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) will release its first quarter 2025 financial results on Friday, May 2, 2025, and will host a conference call the same day. prnewswire.com - 2 weeks ago
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression Policy update increases access for millions covered by Evernorth Health Services Policy update increases access for millions covered by Evernorth Health Services globenewswire.com - 2 weeks ago
The Cigna Group: Compelling Exposure To Diversified Healthcare At A Discount Price Cigna is positioned to benefit from utilization normalization and aims for 10%-14% annual EPS growth by reducing Medicare exposure and improving Commercial business. Despite industry challenges, Cigna achieved 8%-9% YoY EPS growth in 2023-2024, demonstrating strong cost discipline and effective management. The sale of Cigna's Medicare unit and focus on lower-cost biosimilars and streamlined care accessibility are key strategic moves for future growth. seekingalpha.com - 2 weeks ago
MissionSquare Retirement Earns 2024 Cigna Healthy Workforce Designation™ for the second year in a row Washington, D.C., March 26, 2025 (GLOBE NEWSWIRE) -- Cigna Healthcare has selected MissionSquare, an organization that advocates for retirement security and financial well-being, as a recipient of their 2024 Gold Healthy Workforce Designation for demonstrating a strong commitment to improving the health and vitality of its employees through a workplace well-being program. globenewswire.com - 3 weeks ago
New Strong Sell Stocks for March 20th AIN, EFX and CI have been added to the Zacks Rank #5 (Strong Sell) List on March 20, 2025. zacks.com - 4 weeks ago
The Cigna Group Completes Sale of Medicare Businesses to HCSC BLOOMFIELD, Conn. , March 19, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) today announced the successful completion of the sale of its Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses to Health Care Service Corporation (HCSC). prnewswire.com - 1 month ago
Cigna shuffles executive roles, names Ann Dennison as CFO Cigna has made a series of upper management changes, which include making CFO Brian Evanko as the healthcare conglomerate's chief operating officer, and promoting his deputy Ann Dennison to the top finance role. reuters.com - 1 month ago
The Cigna Group announces leadership changes to accelerate the company's growth strategy Brian Evanko named President and Chief Operating Officer, The Cigna Group Ann Dennison named Executive Vice President and Chief Financial Officer, The Cigna Group Nicole Jones, Chief Administrative Officer and General Counsel, to assume oversight of Enterprise Marketing Eric Palmer, President and Chief Executive Officer of Evernorth Health Services, to depart The Cigna Group Reaffirms Full Year 2025 Financial Outlook BLOOMFIELD, Conn. , March 13, 2025 /PRNewswire/ -- The Cigna Group (NYSE: CI), a global health company, today announced leadership changes designed to further drive the company's focus on customers and patients and accelerate its growth strategy. prnewswire.com - 1 month ago
The Cigna Group (CI) Barclays 27th Annual Global Healthcare Conference (Transcript) The Cigna Group (NYSE:CI ) Barclays 27th Annual Global Healthcare Conference Call March 12, 2025 2:00 PM ET Company Participants Brian Evanko - Chief Financial Officer of Cigna Group, President, Chief Executive Officer of Cigna Healthcare Conference Call Participants Andrew Mok - Barclays Andrew Mok Hi, good afternoon and welcome back to the Barclays Global Healthcare Conference. My name is Andrew Mok, I'm the facilities and managed care analyst here at Barclays. seekingalpha.com - 1 month ago
5 Relatively Secure And Cheap Dividend Stocks, Yields Upto 8% (March 2025) This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields about 3.63%, we present two other groups of five DGI stocks each, from moderate to high yields of up to 8%. seekingalpha.com - 1 month ago
31 Upcoming Dividend Increases, Including 3 Kings This week sees 31 dividend increases, including three Dividend Kings: Genuine Parts, Commerce Bancshares, and Kimberly-Clark, showcasing impressive financial stability and growth. My investment strategy prioritizes companies with consistently rising dividends and outperforming benchmarks, aiming for long-term wealth accumulation and portfolio prosperity. I use data from the "U.S. Dividend Champions" spreadsheet and NASDAQ to identify companies with at least five years of dividend growth. seekingalpha.com - 1 month ago
The Cigna Group Announces Appearance at Barclays 27th Annual Global Healthcare Conference BLOOMFIELD, Conn. , Feb. 26, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Brian Evanko, EVP and CFO of The Cigna Group, and President and CEO of Cigna Healthcare, will present at Barclays 27th Annual Global Healthcare Conference on March 12, 2025, through a virtual webcast. prnewswire.com - 1 month ago
8. Profile Summary

Cigna Corporation CI

image
COUNTRY US
INDUSTRY Medical - Healthcare Plans
MARKET CAP $ 85.5 B
Dividend Yield 0.49%
Description Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Contact 900 Cottage Grove Road, Bloomfield, CT, 06002 https://www.cigna.com
IPO Date March 31, 1982
Employees 71295
Officers Ms. Jamie Kates Chief Accounting Officer Mr. Phil Austin Head of Strategy & Global Business Development for Cigna International Markets Mr. Ralph Giacobbe Senior Vice President of Investor Relations Mr. Christopher DeRosa M.B.A. Executive Vice President of Business Improvement & Innovation Mr. Dean Morris Mirabella President and GM of Florida & Caribbean Markets Ms. Mary Picerno Chief Nursing Officer Mr. Jason D. Sadler President of International MArkets & President of International Health Cigna Healthcare Kari Knight Stevens Executive Vice President, Chief Human Resources Officer & Corporate Secretary Mr. Eric Paul Palmer Executive Vice President of Enterprise Strategy Ms. Ann M. Dennison Executive Vice President & Chief Financial Officer